Fig. 2From: Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virusSVR-12 changes of WHOQoL-HIV BREF and SF-36 in patients with HCV/HIV co-infection. WHOQoL-HIV BREF = World Health Organization Quality of Life Instruments; SF-36 = Short Form 36Back to article page